Skip to main content
  • Register
  • Help
  • Contact us

Xtant Medical Hldgs Inc (XTNT) USD0.000001

Sell:$1.65 Buy:$1.70 Change: $0.06 (3.43%)
Market closed |  Prices as at close on 7 May 2021 | Switch to live prices |
Sell:$1.65
Buy:$1.70
Change: $0.06 (3.43%)
Market closed |  Prices as at close on 7 May 2021 | Switch to live prices |
Sell:$1.65
Buy:$1.70
Change: $0.06 (3.43%)
Market closed |  Prices as at close on 7 May 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Contact details

Address:
664 Cruiser Ln
BELGRADE
59714-9719
United States
Telephone:
+1 (406) 3880480
Website:
https://xtantmedical.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
XTNT
ISIN:
US98420P3082
Market cap:
$146.54 million
Shares in issue:
86.71 million
Sector:
Health Care Supplies
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Sean Browne
    President, Chief Executive Officer, Director
  • Greg Jensen
    Chief Financial Officer, Vice President - Finance
  • Darrel Holmes
    Chief Operating Officer
  • Kevin Brandt
    Senior Vice President, Chief Commercial Officer
  • Gregory Juda
    Chief Scientific Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.